lower highs and lower lows, back inside the last advance.

Movement

mixed

Sessions measured

279

Delivered

64.3%

Traded value sat inside its own last 60 sessions.

The session’s range sat inside its own last 60.

Each is a rank against this stock's own history, not a comparison with any other stock and not a number from a distribution.

• 7 Oct 2026an outlook changedIndia Ratings and Research Private Limited IND AA+

  outlook only.

  TORNTPHARM filed a credit rating action from India Ratings and Research Private Limited.

  Sources

  Filed

  NSE · 2026-10-07 19:32 IST

  Document

  raw/nse_announcement_docs/2026-10-07/105645eba238_105645eba238_TORNTPHARM_07102026193222_SEIntimationIndiaRatings071026.pdf · SHA-256 105645eba238

  Read from

  “Affirmed the credit rating and revised the outlook from stable to positive of the Company’s existing banking facilities, issuer rating and Non-Convertible Debentures. The rating along with outlook is IND AA+/Positive” · page 1 · characters 1499–1717

  Read by

  claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed

• 28 Sep 2026acquisition, merger or stake sale₹12 crore

  <1% of the company's market value.

  TORNTPHARM filed an acquisition, merger or stake sale of ₹12 crore.

  Sources

  Filed

  NSE · 2026-09-28 12:03 IST

  Document

  raw/nse_announcement_docs/2026-09-28/65cdbf641314_65cdbf641314_TORNTPHARM_28092026120242_SE_intimation_reg_30.pdf · SHA-256 65cdbf641314

  Read from

  “INR 11,87,90,100” · page 1 · characters 1367–1383

  Read by

  claude-haiku-4-5 · prompt 8c43350f344fef0c · 10 of 10 checks passed

an outlook changed of India Ratings and Research Private Limited IND AA+, outlook only.

Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.

• 7 Oct 2026an outlook changedIndia Ratings and Research Private Limited IND AA+

  outlook only.

• 28 Sep 2026acquisition, merger or stake sale₹12 crore

  <1% of the company's market value.

• 30 Jul 2026results

  the move was 0.5-1x what the options priced.

• 20 Jul 2026acquisition, merger or stake sale

  the filing states no amount.

• 7 Jul 2026split, bonus or record date
• 22 May 2026results

  the move was <0.5x what the options priced.

• 22 May 2026dividend
• 13 Feb 2026dividend
• 13 Feb 2026results

  the move was 0.5-1x what the options priced.

• 13 Feb 2026dividend
• 3 Feb 2026acquisition, merger or stake sale

  the filing states no amount.

• 3 Feb 2026dividend
• 19 Jan 2026fund raising₹2,000 crore

  1-3% of the company's market value.

• 19 Jan 2026fund raising₹1,500 crore

  1-3% of the company's market value.

• 5 Jan 2026a rating keptICRA AA+ (Stable)

  reaffirmed; filed on the same session as another filing.

• 5 Jan 2026fund raising₹12,500 crore

  3-10% of the company's market value; filed on the same session as another filing.

• 2 Jan 2026a rating keptIndia Ratings and Research Private Limited IND AA+(Stable)

  reaffirmed.

• 7 Oct 2025a rating keptICRA AA+ (Stable)

  reaffirmed.

• 7 Oct 2025a rating keptIndia Ratings and Research Private Limited IND AA+(Stable)

  reaffirmed.

• 24 Sep 2025fund raising₹200 crore

  <1% of the company's market value.

Every kind of filing, across the market

Counts from this stock's own record: on how many of the days it stood in that state the close that many sessions later was higher. A greyed row has fewer than 30 such days, too few to read as a tendency, and its counts are printed anyway. A day whose later session has not arrived is not counted.